Salk Institute

Technologies Available for Licensing

Search Results - epinephrine

1 Results Sort By:
Nurr1: A Novel Target for the Treatment of Catecholamine Related Diseases
Nurr1: A Novel Target for the Treatment of Catecholamine Related Diseases Nurr1 is a polypeptide that upregulates tyrosine hydroxylase activity and promotes expression of DOPA, epinephrine and norepinephrine. This could be useful for the treatment of catecholamine related diseases, such as Parkinson's, manic depression, and schizophrenia. I...
Published: 8/2/2013   |   Inventor(s):  
Keywords(s): Catecholamine, DOPA, Epinephrine, Gene Therapy, Manic depression, Neurodegenerative Disorders, norepinephrine, Nurr1, Parkinson's, Regenerative Medicine, Schizophrenia, Stem Cells, Tyrosine hydroxylase
Category(s): Regenerative Medicine, Neurosciences and Ophthalmology
© 2017. All Rights Reserved. Powered by Inteum      

Get Involved
Join our online community
Facebook    Facebook
Twitter    Twitter
YouTube    YouTube
RSS    RSS
Contact
Salk Institute for Biological Studies
Street: 10010 North Torrey Pines Rd
City: La Jolla, CA 92037
Email: webrequest@salk.edu
Phone: 858.453.4100
Charity Navigator Rating
© Copyright 2012 Salk Institute for Biological Studies About Scientists & Research News & Media Events Support